155043-84-8Relevant articles and documents
An efficient synthesis of the anti-asthmatic agent T-440: A selective N- alkylation of 2-pyridone
Sugahara, Masakatsu,Moritani, Yasunori,Kuroda, Tooru,Kondo, Kazuhiko,Shimadzu, Hideshi,Ukita, Tatsuzo
, p. 589 - 591 (2000)
6,7-Diethoxy-1-[1-(2-methoxyethyl)-2-oxo-1,2-dihydropyridin-4- yl]naphthalene-2,3-dimethanol [T-440, (1)] is a potential anti-asthmatic agent based on selective phosphodiesterase 4 inhibition. It was necessary for the further evaluation of 1 to develop an
TERTIARY AMINES, MEDICAMENTS CONTAINING SAID AMINES, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF
-
Paragraph 0550, (2013/12/04)
The present invention relates to compounds of general formula (I) and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.
Novel selective PDE IV inhibitors as antiasthmatic agents. Synthesis and biological activities of a series of 1-aryl-2,3- bis(hydroxymethyl)naphthalene lignans
Iwasaki, Tameo,Kondo, Kazuhiko,Kuroda, Tooru,Moritani, Yasunori,Yamagata, Shinsuke,Sugiura, Masaki,Kikkawa, Hideo,Kaminuma, Osamu,Ikezawa, Katsuo
, p. 2696 - 2704 (2007/10/03)
A series of 1-aryl-2,3-bis(hydroxymethyl)naphthalene lignans have been synthesized and evaluated for their ability to selectively inhibit PDE IV isolated from guinea pig. Replacement of the 1-phenyl ring by a pyridone ring led to marked improvement of the
Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor
-
, (2008/06/13)
Naphthalene derivative of the formula [I]: STR1 wherein R1 and R2 are the same or different and are hydrogen atom, hydroxy group, cyclo-lower alkyloxy group, substituted or unsubstituted lower alkoxy group, or both combine each other to form lower alkylenedioxy group, R3 is substituted or unsubstituted nitrogen-containing 6-membered heterocyclic group, and groups of the formulae: --OR4 and --OR5 are the same or different and are protected or unprotected hydroxy group, processes for preparing thereof, and synthetic intermediates therefor, these compounds have excellent bronchodilating activity, and are useful in the prophylaxis and treatment of asthma.